You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

SPECTAZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Spectazole patents expire, and when can generic versions of Spectazole launch?

Spectazole is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in SPECTAZOLE is econazole nitrate. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the econazole nitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Spectazole

A generic version of SPECTAZOLE was approved as econazole nitrate by TARO on November 26th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SPECTAZOLE?
  • What are the global sales for SPECTAZOLE?
  • What is Average Wholesale Price for SPECTAZOLE?
Summary for SPECTAZOLE
Drug patent expirations by year for SPECTAZOLE

US Patents and Regulatory Information for SPECTAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.